Endo International plc ENDP shares were trading lower Thursday after the company announced it will present data on the use of a standing MRI versus a prone MRI for the evaluation of cellulite at the Annual Meeting of the American Society for Dermatologic Surgery in Chicago.
The company said it will display two posters from Thursday through Sunday.
The first poster is a case study comparison of the use of a standing MRI versus a prone MRI for the evaluation of cellulite.
The second poster is an encore presentation of the Phase 3 data of collagenase clostridium histolyticum for the investigational treatment of cellulite.
Endo shares were down 7.16% at $4.41 at the time of publication.
Related Link: Momentum Stock Soliton Continues Rally Following News Of Cellulite Trial Initiation
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
